Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04045600 · ClinicalTrials.gov registry record · NA
Refinements of Functional Communication Training
A NA study of Aggression and Self Injurious Behavior, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT04045600: Recruiting NA study of Aggression and Self Injurious Behavior, sponsored by Rutgers, The State University of New Jersey.
NCT04045600 is a NA study of Aggression and Self Injurious Behavior that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 24 participants, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04045600, a NA study of Aggression and Self Injurious Behavior, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Although treatments for problem behavior, like functional communication training (FCT), can be highly effective in the clinic, changes in the way the FCT is implemented (e.g., when transferring treatment to the home, when teachers implement treatment with poor fidelity) can result in treatment relapse. The goal of this study is to evaluate whether using treatment signals and gradually introducing materials from natural contexts can help mitigate treatment relapse during context changes and poor treatment-integrity scenarios.
Primary Outcome
The investigators will measure the rate of destructive behavior following successful treatment when the FCT is implemented in a context not associated with treatment (e.g., the baseline, home-like context).
Conditions Studied
Interventions
- BEHAVIORAL Trad FCT
- BEHAVIORAL Mult FCT
- BEHAVIORAL Mult FCT + Stimulus Fading
Study Locations (1)
New Jersey
- Children's Specialized Hospital - Rutgers University Center for Autism Research, Education, and Services - Somerset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT04045600 shows while recruiting
NCT04045600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Aggression appearing as the primary indexed condition, and to 3 interventions - of which Trad FCT is the first listed.
NCT04045600 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04045600 about?
NCT04045600 is a clinical study titled "Refinements of Functional Communication Training". Although treatments for problem behavior, like functional communication training (FCT), can be highly effective in the clinic, changes in the way the FCT is implemented (e.g., when transferring treatment to the home, when teachers implement treatment with poor fidelity) can result in treatment relap...
What is the current status of trial NCT04045600?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2021-05-03. Estimated completion is 2025-12-31.
What conditions does trial NCT04045600 study?
This clinical trial studies the following conditions: Aggression, Self Injurious Behavior.
What interventions are being tested in trial NCT04045600?
The interventions under investigation include: Trad FCT (BEHAVIORAL), Mult FCT (BEHAVIORAL), Mult FCT + Stimulus Fading (BEHAVIORAL).
Who is sponsoring clinical trial NCT04045600?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04045600 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04045600's enrollment target sits among peer trials
24 20th of 21 higher than 2 of 21 other Aggression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
RECRUITING · NA
-
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
RECRUITING · NA
-
Basic and Applied Research on Extinction Bursts
RECRUITING · NA
-
Just-In-Time Intervention to Reduce Alcohol-Facilitated Intimate Partner Violence Perpetration
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI